GENB
GENB
US3709201004
Generate Biomedicines, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Market & Enterprise Value
Market Cap
1.84B EUR
2.16B EUR
Enterprise Value
1.4B EUR
2.09B EUR
Valuation Multiples
Trailing P/E
--
--
Forward P/E
-6.29x
--
Price to Sales
69.5x
66.61x
Price to Book
4.03x
4.74x
EV/Revenue
52.9x
64.37x
EV/EBITDA
-5.61x
--
Price to FCF (P/FCF)
--
--
EV/FCF
--
--
FCF Yield
--
-11.36%
ende